Literature DB >> 30178097

[Potential new treatment strategies for B‑cell lymphomas].

M Heuser1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30178097     DOI： 10.1007/s00108-018-0487-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  3 in total

1.  Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.

Authors:  Michael Crump; Sattva S Neelapu; Umar Farooq; Eric Van Den Neste; John Kuruvilla; Jason Westin; Brian K Link; Annette Hay; James R Cerhan; Liting Zhu; Sami Boussetta; Lei Feng; Matthew J Maurer; Lynn Navale; Jeff Wiezorek; William Y Go; Christian Gisselbrecht
Journal:  Blood       Date:  2017-08-03       Impact factor: 22.113

Review 2.  The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL).

Authors:  S G Papageorgiou; K Cwynarski; P D Kottaridis
Journal:  Bone Marrow Transplant       Date:  2013-01-14       Impact factor: 5.483

Review 3.  Chimeric antigen receptor T-cell therapies for lymphoma.

Authors:  Jennifer N Brudno; James N Kochenderfer
Journal:  Nat Rev Clin Oncol       Date:  2017-08-31       Impact factor: 66.675
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.